(Q44249049)

1 December 2017

Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta2-microglobulin, and clinical stage in multiple myeloma (English)

1 reference

1 December 2017

0 references

Vladimir Jurisić

1

1 reference

PubMed ID

12482123

1 December 2017

Milica Colović

series ordinal

2

1 reference

1 December 2017

1 January 2002

1 reference

1 December 2017

1 reference

1 December 2017

19

1 reference

1 December 2017

3

1 reference

1 December 2017

133-139

1 reference

https://scigraph.springernature.com/pub.10.1385/mo:19:3:133

1 December 2017

0 references

cites work

A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity

1 reference

12 December 2020

[Level of interleukin-6 (IL-6), soluble interleukin-6 receptors (sIL-6R) and tumor necrosis factor alpha (TNF-alpha) in untreated and progressing multiple myeloma]

1 reference

12 December 2020

TNF and IL-6 are potent growth factors for OH-2, a novel human myeloma cell line.

1 reference

12 December 2020

Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients

1 reference

12 December 2020

Increased T cell cytotoxicity by Betathine-induced upregulation of TNFalpha

1 reference

12 December 2020

Different alterations in lactate dehydrogenase activity and profile of peripheral blood mononuclear cells in Hodgkin's and non-Hodgkin's lymphomas

1 reference

12 December 2020

Measurement of serum cytokine levels in patients with myelodysplastic syndromes

1 reference

12 December 2020

TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase

1 reference

12 December 2020

Interleukin 6, tumour necrosis factor alpha and lymphotoxin alpha polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma

1 reference

12 December 2020

Apoptosis, proliferation and NF-kappaB activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor

1 reference

12 December 2020

High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.

1 reference

12 December 2020

Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.

1 reference

12 December 2020

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

12 December 2020

Multiple myeloma in elderly patients: presenting features and outcome

1 reference

12 December 2020

Multiple myeloma: increasing evidence for a multistep transformation process

1 reference

12 December 2020

A comparison of the NK cell cytotoxicity with effects of TNF-alpha against K-562 cells, determined by LDH release assay

1 reference

12 December 2020

Autocrine growth by two cytokines, interleukin-6 and tumor necrosis factor alpha, in the myeloma cell line KHM-1A.

1 reference

12 December 2020

The role of human and viral cytokines in the pathogenesis of multiple myeloma

1 reference

12 December 2020

Identifiers

DOI

10.1385/MO:19:3:133

1 reference

PubMed ID

12482123

Dimensions Publication ID

1 December 2017

0 references

1 reference

PubMed ID

12482123